Home / Import refusals / 112-1381865-6/2/1

FDA Import Refusal 112-1381865-6/2/1 — GlaxoSmithKline LLC

GlaxoSmithKline LLC — FEI 1033964

The FDA refused shipment 112-1381865-6/2/1 from GlaxoSmithKline LLC (United States) on August 24, 2011. The refused product falls under Drugs and Biologics — GLIMEPIRIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
August 24, 2011
Country
United States
Product Category
Drugs and Biologics
Product Code
61PCA31 GLIMEPIRIDE (ANTI-DIABETIC)
Charges
75

Recent inspections

  • 1298596 (NAI Fri Feb 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1229588 (VAI Fri Apr 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1043270 (NAI Fri Jan 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 987392 (VAI Thu Apr 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 940149 (NAI Fri Aug 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 1FX-0333205-3/10002/1 (Fri Jun 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-9324952-1/30002/1 (Tue Jun 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • NUV-3881703-0/70002/1 (Tue Feb 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9318923-9/110002/1 (Thu Feb 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9449370-5/10003/1 (Fri Feb 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources